There are ways to make medicines accessible
Article Abstract:
Drugs have been cost-effective forms of treatment for many years, although not accessible due to high prices. Current pharmaceutical prices are reasonable considering the money and risk involved in developing new drugs, and the percentage of gross national product spent on pharmaceuticals has remained at .5% for the past 30 years. However, these arguments mean little to someone who cannot afford his or her medication. Reducing drug company profits is unrealistic, but poor patients must be ensured access to medicines through programs set up by pharmaceutical firms and through public and private insurance companies.
Publication Name: American Medical News
Subject: Health
ISSN: 0001-1843
Year: 1993
User Contributions:
Comment about this article or add new information about this topic:
No fleeing of healthy because of community rating
Article Abstract:
Henry Kaiser Family Foundation's Innovations report indicates that the 'pure' community rating laws in New Jersey and New York have not resulted in higher insurance premiums or other problems for individuals and the small-group market. Instead, the number of insurance policies increased by about 30% after a law was passed in New Jersey. The laws help establish a fair market for many more people who want to be covered by insurance.
Publication Name: American Medical News
Subject: Health
ISSN: 0001-1843
Year: 1995
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: A skeptic's guide to sports medicine. The 10 hidden causes of fatigue
- Abstracts: Taking the message to Washington. Lesson of health reform learned through tickets for lunch. U.S., Canada: health care demands considerably different
- Abstracts: How to make change. The star treatments
- Abstracts: Breast-feeding: time to teach what we preach. Policies and practices related to the role of board certification and recertification of pediatricians in hospital privileging
- Abstracts: Platelets and coronary artery disease. A 70-year-old woman with atrial fibrillation and the rapid onset of hemorrhagic manifestations